MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Hallucinations"

  • 2019 International Congress

    Daily variability of non-motor symptoms as a reflection of circadian dysregulation in Parkinson’s disease

    O. Alenikova, S. Likhchev, A. Buniak, M. Liashkovich (Minsk, Belarus)

    Objective: To assess the daily variability of visual and autonomic nervous system (ANS) functions in relation to sleep disorders to determine circadian PD phenotypes Background:…
  • 2019 International Congress

    Olfactory Hallucinations as a Non-motor sign of Parkinson’s disease- a cross sectional study

    S. Chandra, M. Schiess, R. Mehanna (Houston, TX, USA)

    Objective: To describe the prevalence and characteristics of Olfactory Hallucinations (OlfH) in patients with Parkinson’s Disease (PD) in a tertiary movement clinic. Background: Hallucinations are…
  • 2019 International Congress

    Relationship between RBD and olfactory disorder, clinical symptoms in Parkinson’s disease

    M. Iijima, F. Yoshi, K. Suzuki, S. Nogawa, T. Osada, H. Hirata, K. Kitagawa, N. Hattori, Y. Okuma (Tokyo, Japan)

    Objective: We aimed to assess the association among RBD, olfactory function and clinical symptoms in patients with Parkinson's disease (PD). Background: Rapid eye movement sleep…
  • 2019 International Congress

    Visual subnetwork dysfunction in Parkinson’s patients with primary visual hallucinations

    S. Rane, A. Lenka, S. Prasad, J. Saini, M. Ingalhalikar, P. Pal (Seatle, WA, USA)

    Objective: To evaluate impairments in the visual subnetwork in Parkinson’s disease (PD) patients with psychosis using BOLD fMRI Background: Psychosis occurs in 20-70% of patients…
  • 2019 International Congress

    Olfactory Hallucinations Induced by Pramipexole Treatment in Parkinson’s Disease

    G. Hatipoglu, S. Ozkaynak (Antalya, Turkey)

    Objective: In the treatment of Parkinson’s disease, dopamine agonists are among the preferred treatment options, particularly in the treatment of young Parkinson’s patients. The known…
  • 2019 International Congress

    Rivastigmine for visual hallucinations in Parkinson’s disease

    T. Mierlo, E. Foncke, R. Bie (Amsterdam, Netherlands)

    Objective: The aim of the study is to investigate whether early rivastigmine treatment of visual hallucinations in patients with Parkinson's disease delays the progression of…
  • 2019 International Congress

    The role of dysfunctional attentional processing in isolated minor hallucinations in Parkinson’s disease

    H. Bejr-Kasem, J. Pagonabarraga, S. Martínez-Horta, F. Ruiz-Martínez, F. Bernasconi, F. Sampedro, J. Marín-Lahoz, A. Horta-Barba, I. Aracil-Bolaños, B. Pascual-Sedano, O. Blanke, J. Kulisevsky (Barcelona, Spain)

    Objective: To explore attentional processing deficits in Parkinson's disease (PD) with minor hallucinations using a selective visual attention task. Background: Recent literature points to a…
  • 2019 International Congress

    Frequency of neuropsychiatric symptoms in non-demented early and late-onset Parkinson’s disease patients

    A. Seubert-Ravelo, MG. Yáñez-Téllez, G. Neri-Nani, X. Ortiz-Jiménez, C. Guerra-Galicia (Estado de México, Mexico)

    Objective: To compare the frequency of neuropsychiatric symptoms (NPS) (depression, anxiety, psychotic, irritability, aggression, euphoria, apathy, behavioral disinhibition, repetitive motor behavior (RMB) and eating disorder)…
  • 2019 International Congress

    Correlation between Pareidolia and cerebral perfusion by SPECT in Parkinson’s disease without dementia: A retrospective study

    H. Akamine, T. Tokashiki (Ginowan, Japan)

    Objective: The aim of this study is to investigate the correlation between the number of illusory responses on the Pareidolia test and cerebral perfusion in…
  • 2018 International Congress

    Lewy body disease with visual hallucination: Optic radiation abnormalities on phase difference-enhanced imaging (PADRE)

    M. Miyata, S. Kakeda, T. Yoneda, K. Okada, H. Adachi, Y. Korogi (Kitakyushu, Japan)

    Objective: We assessed structural abnormalities of optic radiation (OR) in healthy subjects (HS) and dementia with lewy body (DLB) patients (with visual hallucination) (VH) on…
  • « Previous Page
  • 1
  • …
  • 4
  • 5
  • 6
  • 7
  • 8
  • …
  • 11
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley